Annual Accounts Receivable
$15.20 M
-$534.00 K-3.39%
December 31, 2023
Summary
- As of February 7, 2025, GYRE annual accounts receivable is $15.20 million, with the most recent change of -$534.00 thousand (-3.39%) on December 31, 2023.
- During the last 3 years, GYRE annual accounts receivable has risen by +$5.15 million (+51.29%).
- GYRE annual accounts receivable is now -3.39% below its all-time high of $15.74 million, reached on December 31, 2022.
Performance
GYRE Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$19.54 M
+$1.08 M+5.84%
September 30, 2024
Summary
- As of February 7, 2025, GYRE quarterly accounts receivable is $19.54 million, with the most recent change of +$1.08 million (+5.84%) on September 30, 2024.
- Over the past year, GYRE quarterly accounts receivable has increased by +$4.33 million (+28.51%).
- GYRE quarterly accounts receivable is now at all-time high.
Performance
GYRE Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
GYRE Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -3.4% | +28.5% |
| 3 y3 years | +51.3% | +56.5% |
| 5 y5 years | +51.3% | +56.5% |
GYRE Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -3.4% | +51.3% | at high | +56.5% |
| 5 y | 5-year | -3.4% | +51.3% | at high | +56.5% |
| alltime | all time | -3.4% | +51.3% | at high | +56.5% |
Gyre Therapeutics Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $19.54 M(+5.8%) |
| Jun 2024 | - | $18.46 M(+21.4%) |
| Mar 2024 | - | $15.21 M(+0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $15.20 M(-3.4%) | $15.20 M(+21.8%) |
| Mar 2023 | - | $12.49 M |
| Dec 2022 | $15.74 M(+56.6%) | - |
| Dec 2021 | $10.05 M | - |
FAQ
- What is Gyre Therapeutics annual accounts receivable?
- What is the all time high annual accounts receivable for Gyre Therapeutics?
- What is Gyre Therapeutics annual accounts receivable year-on-year change?
- What is Gyre Therapeutics quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Gyre Therapeutics?
- What is Gyre Therapeutics quarterly accounts receivable year-on-year change?
What is Gyre Therapeutics annual accounts receivable?
The current annual accounts receivable of GYRE is $15.20 M
What is the all time high annual accounts receivable for Gyre Therapeutics?
Gyre Therapeutics all-time high annual accounts receivable is $15.74 M
What is Gyre Therapeutics annual accounts receivable year-on-year change?
Over the past year, GYRE annual accounts receivable has changed by -$534.00 K (-3.39%)
What is Gyre Therapeutics quarterly accounts receivable?
The current quarterly accounts receivable of GYRE is $19.54 M
What is the all time high quarterly accounts receivable for Gyre Therapeutics?
Gyre Therapeutics all-time high quarterly accounts receivable is $19.54 M
What is Gyre Therapeutics quarterly accounts receivable year-on-year change?
Over the past year, GYRE quarterly accounts receivable has changed by +$4.33 M (+28.51%)